avateramedical to present at ERUS meeting after successful completion of first live surgery at DRUS congress

AiCuris’ Licensing Partner MSD Demonstrates Efficacy in Phase 3 Study with PREVYMIS® for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation

Atriva Therapeutics to take part in upcoming industry and investor conferences

Marinomed: First successful year on the market for Marinomed’s Solv4U technology partnerships

Apogenix’ Asunercept Demonstrates Efficacy in Phase II Trial for the Treatment of Hospitalized COVID-19 Patients

Spexis to present at BIO-Europe® 2022

Rentschler Biopharma appoints Tobias Glueck as Senior Vice President Human Relations

Adrenomed to attend upcoming industry and investor conferences

avateramedical to attend several upcoming scientific meetings to demonstrate its system for robot-assisted surgery

ABIVAX: FIRST US PATIENT ENROLLED IN GLOBAL PHASE 3 PROGRAM WITH OBEFAZIMOD IN ULCERATIVE COLITIS